OMEROS CORP
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
OMER$17.55+3.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
| | March 31, | December 31, |
|---|---|---|
| | 2024 | 2023 |
| Assets | | |
| Current assets: | | |
| Cash and cash equivalents | $1,831 | $7,105 |
| Short-term investments | 228,503 | 164,743 |
| OMIDRIA contract royalty asset, short-term | 29,519 | 29,373 |
| Receivables | 7,642 | 8,096 |
| Prepaid expense and other assets | 13,463 | 8,581 |
| Total current assets | 280,958 | 217,898 |
| OMIDRIA contract royalty asset | 135,909 | 138,736 |
| Right of use assets | 17,767 | 18,631 |
| Property and equipment, net | 1,804 | 1,950 |
| Restricted investments | 1,054 | 1,054 |
| Total assets | $437,492 | $378,269 |
| | | |
| Liabilities and shareholders’ equity (deficit) | ||
| Current liabilities: | ||
| Accounts payable | $6,182 | $7,712 |
| Accrued expenses | 28,402 | 31,868 |
| Current portion of OMIDRIA royalty obligation | 19,130 | 8,576 |
| Current portion of lease liabilities | 5,342 | 5,160 |
| Total current liabilities | 59,056 | 53,316 |
| Convertible senior notes, net | 213,463 | 213,155 |
| OMIDRIA royalty obligation, non-current | 217,459 | 116,550 |
| Lease liabilities, non-current | 16,754 | 18,143 |
| Other accrued liabilities, non-current | 2,088 | 2,088 |
| Commitments and contingencies (Note 10) | ||
| Shareholders’ equity (deficit): | ||
| Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at March 31, 2024 and December 31, 2023. | — | — |
| Common stock, par value $0.01 per share, 150,000,000 shares authorized at March 31, 2024 and December 31, 2023; 57,942,695 and 61,128,597 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively. | 579 | 611 |
| Additional paid-in capital | 718,807 | 727,936 |
| Accumulated deficit | (790,714) | (753,530) |
| Total shareholders’ deficit | (71,328) | (24,983) |
| Total liabilities and shareholders’ equity (deficit) | $437,492 | $378,269 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.